当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析

君实生物-U

(688180)

  

流通市值:289.62亿  总市值:387.99亿
流通股本:7.66亿   总股本:10.27亿

君实生物-U(688180)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-6.74亿元,每股收益-0.60元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益629531.94万元,未分配利润-1093669.34万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1168804.16万元,负债539272.22万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,805,880,133.521,168,383,949.66500,591,459.941,948,317,315.72
营业总成本2,473,163,074.831,659,107,714.05782,539,195.353,215,859,236.06
其他经营收益
营业利润-671,058,241.61-475,011,078.54-281,715,865.28-1,338,824,837.02
利润总额-692,393,121.41-485,211,590.12-286,837,114.51-1,357,557,181.39
净利润-674,309,869.11-465,673,412.19-259,586,438.78-1,380,108,858.26
每股收益
其他综合收益-146,608.69-15,916,155.46-10,204,644.58-17,870,045.74
综合收益总额-674,456,477.8-481,589,567.65-269,791,083.36-1,397,978,904
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计4,445,064,264.394,784,755,600.844,255,015,311.224,283,817,107.05
非流动资产:
非流动资产合计7,242,977,370.966,890,832,474.916,642,054,455.586,498,143,303.05
资产总计11,688,041,635.3511,675,588,075.7510,897,069,766.810,781,960,410.1
流动负债:
流动负债合计2,748,630,846.132,968,737,939.933,044,658,054.062,493,923,829.63
非流动负债:
非流动负债合计2,644,091,377.342,314,733,583.042,183,251,649.142,355,906,816.32
负债合计5,392,722,223.475,283,471,522.975,227,909,703.24,849,830,645.95
所有者权益(或股东权益):
归属于母公司股东权益合计6,216,157,386.496,372,334,459.95,620,244,628.635,860,424,336.29
股东权益合计6,295,319,411.886,392,116,552.785,669,160,063.65,932,129,764.15
负债和股东权益合计11,688,041,635.3511,675,588,075.7510,897,069,766.810,781,960,410.1
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,139,612,068.291,404,458,148.66803,419,825.511,916,527,984.34
经营活动现金流出小计2,483,022,336.461,733,846,482827,751,022.013,350,369,193.88
经营活动产生的现金流量净额-343,410,268.17-329,388,333.34-24,331,196.5-1,433,841,209.54
投资活动产生的现金流量:
投资活动现金流入小计1,718,649,206.71,207,614,304.91490,394,088.861,957,267,588.79
投资活动现金流出小计2,627,438,852.341,760,468,211.27832,019,803.482,850,049,722.35
投资活动产生的现金流量净额-908,789,645.64-552,853,906.36-341,625,714.62-892,782,133.56
筹资活动产生的现金流量:
筹资活动现金流入小计3,533,008,134.162,640,106,775.131,422,331,063.182,314,600,434.75
筹资活动现金流出小计1,990,436,816.31,255,742,433.161,035,553,067.931,291,454,659.77
筹资活动产生的现金流量净额1,542,571,317.861,384,364,341.97386,777,995.251,023,145,774.98
汇率变动对现金及现金等价物的影响-7,377,820.48376,249.04-791,648.4312,014,641.06
现金及现金等价物净增加额282,993,583.57502,498,351.3120,029,435.7-1,291,462,927.06
期末现金及现金等价物余额2,769,672,692.392,989,177,460.132,506,708,544.522,486,679,108.82
补充资料:
现金及现金等价物的净增加额-502,498,351.31--1,291,462,927.06
最新报告期:2025-11-03
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
光大证券吴佳青,王明瑞-0.87-0.280.102025-11-03
太平洋周豫,戎晓婕-0.93-0.410.042025-10-29
天风证券杨松,曹文清-0.66-0.140.182025-10-08
太平洋周豫,戎晓婕-0.93-0.410.042025-08-30
方正证券许睿,周超泽-0.670.040.312025-08-26
TOP↑